机构名称：
¥ 1.0
COVID-19疫苗LMIC推出的关键战略决策正在专门用于采购Covid-19-19疫苗对LMICS的采购（尽管迄今为止采购的剂量仍然不足以覆盖LMIC种群），但在计划和实施集团内推销方面投入了很多资金。Covax最近的报告表明，在国内疫苗推出的费用约为每剂1.5美元，以便提供疫苗以覆盖人口的前20％，而不包括医疗保健劳动力的成本。Of this, COVAX has estimated that approximately $1 per dose would need to come from sources other than COVAX (for example, domestic, bilateral, or multilateral sources) at an estimated total of $1.3 billion.⁸ COVAX already expects to provide more than 20 percent population coverage by the end of 2021, and many LMICs have sourced additional doses through regional and bilateral deals, so the total rollout funding requirement仅在2021年就可能要大得多。尽管从理论上讲，世界银行的120亿美元贷款计划可以用于疫苗交付活动，但尚不清楚各国是否会选择使用这种融资机制。
低收入国家和中等收入国家的COVID-19疫苗推出
主要关键词
相关文件推荐
